- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Chemical process.
Displaying page 1 of 1.
| EudraCT Number: 2015-003556-44 | Sponsor Protocol Number: IMEA048 | Start Date*: 2016-05-17 |
| Sponsor Name:IMEA Fondation Leon Mba | ||
| Full Title: Phase 2 Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Chikungunya Virus-Like Particle Vaccine,VRC-CHKVLP059-00-VP, in Healthy Adults | ||
| Medical condition: To evaluate the safety and tolerability of VRC-CHKVLP059-00-VP vaccin in healthy adults that reside in CHIKV endemic . | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003077-42 | Sponsor Protocol Number: CE01-204 | Start Date*: 2015-02-06 | |||||||||||
| Sponsor Name:Imperial College, London | |||||||||||||
| Full Title: A single-centre, double-blind, randomised, placebo-controlled crossover study to evaluate the effect of solithromycin on airway inflammation in male and female patients with chronic obstructive pul... | |||||||||||||
| Medical condition: Chronic Obstructive Pulmonary Disease. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-004599-19 | Sponsor Protocol Number: INTERFANT-06 | Start Date*: 2005-11-24 | |||||||||||
| Sponsor Name:A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA | |||||||||||||
| Full Title: INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA | |||||||||||||
| Medical condition: acute lymphoblastic leukemia (ALL) or biphenotypic leukemia | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) BE (Completed) FR (Ongoing) DE (Completed) GB (Completed) AT (Completed) PT (Completed) DK (Completed) IE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-000748-32 | Sponsor Protocol Number: SPI-62-CL-2002 | Start Date*: 2023-08-29 | |||||||||||
| Sponsor Name:Sparrow Pharmaceuticals, Inc. | |||||||||||||
| Full Title: SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor | |||||||||||||
| Medical condition: Hypercortisolism Related to a Benign Adrenal Tumor | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Prematurely Ended) RO (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.